Peter Andre breaks his silence on rumours his daughter Princess is following in her parents' footsteps by landing her own reality show
The 17-year-old has grown up in the spotlight thanks to her famous parents' many TV projects over the years, with her birth ...
Virginia Mercury4dOpinion
Why the PDAB bill deserves Gov. Youngkin’s veto
If Virginia establishes a Prescription Drug Affordability Board, it could make it harder for families like mine to access ...
Soleno Therapeutics: FDA Approval May Prove To Be A Pyrrhic Victory
Soleno Therapeutics is nearing FDA approval for its lead drug, DCCR, targeting Prader-Willi Syndrome, a rare genetic ...
Katie Price gives heartbreaking update on son Harvey as she reveals he refused to go back to college
KATIE Price has given an emotional update on eldest son Harvey as she told how he has refused to go back to college. Harvey, ...
Sen. Kelly hosts town hall in Tucson to discuss impacts of potential Medicaid cuts
TUCSON, Ariz. (13 News) - For the second time in less than a week, Sen. Mark Kelly hosted a town hall to discuss what ...
Is ACADIA Pharmaceuticals Inc. (ACAD) a Promising Biotech Stock According to Wall Street Analysts
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
American Association of Individual Investors2d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Up 32.48%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 32.48%, which has investors questioning if this is right time to sell.
American Association of Individual Investors4d
Which Is a Better Investment, Elanco Animal Health Incorporated or Harmony Biosciences Holdings, Inc. Stock?
Learn more about whether Elanco Animal Health Incorporated or Harmony Biosciences Holdings, Inc. is a better investment based ...
Charles Schwab Investment Management Inc. Buys 24,953 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Charles Schwab Investment Management Inc. raised its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) ...
748 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Acquired by US Bancorp DE
US Bancorp DE purchased a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 748 ...